2011
DOI: 10.1111/j.1464-410x.2011.10332.x
|View full text |Cite
|
Sign up to set email alerts
|

Seminal vesicle invasion: what is the best adjuvant treatment after radical prostatectomy?

Abstract: Study Type – Therapy (individual cohort) Level of Evidence 2b What’s known on the subject? and What does the study add? Seminal vesicle invasion in prostate cancer has a poor prognosis. Nowadays, there is no consensus about the best adjuvant treatment after radical prostatectomy when seminal vesicle invasion is observed in the specimen. To our knowledge, this is the first comparative study between different adjuvant treatments after radical prostatectomy when seminal vesicle invasion is observed in the specime… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
21
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(26 citation statements)
references
References 26 publications
4
21
0
Order By: Relevance
“…In an attempt to determine the optimal treatment for patients with SVI after RP, Bastide and colleagues evaluated BCR according to different adjuvant treatments. They report that RP appears to be insufficient as monotherapy in patients with SVI, however ADT in combination with adjuvant RT provided substantial biochemical control benefit 8 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In an attempt to determine the optimal treatment for patients with SVI after RP, Bastide and colleagues evaluated BCR according to different adjuvant treatments. They report that RP appears to be insufficient as monotherapy in patients with SVI, however ADT in combination with adjuvant RT provided substantial biochemical control benefit 8 .…”
Section: Discussionmentioning
confidence: 99%
“…They demonstrated that AA men had a significantly higher prevalence of anterior cancer foci of higher grade and larger volume as compared to Caucasian men 8 . Whether differing patterns of local disease progression between race groups may account for worse outcomes in AA men following RP is currently unknown.…”
Section: Introductionmentioning
confidence: 99%
“…However, the 10-yr OS was similar between groups (75% vs. 69%, P = 0.12). A cohort study by Bastide et al also compared the use of RP ( N = 82) with RP plus aADT ( N = 41) for pT3bN0M0 patients23. Multivariate analysis showed that the combined group had a lower PSA-biochemical recurrence rate (HR 0.64, P = 0.13).…”
Section: Resultsmentioning
confidence: 99%
“…ADT use before surgery or radiotherapy was based on “the first hypothesis” that androgen ablation might reduce the tumor bulk and enhance tumor cell kill to enable total excision of the cancerous area, whereas ADT use after surgery or radiotherapy might eliminate residual tumor cells in the primary lesions and subclinical metastatic lesions (called “the second hypothesis”). Studies by Siddiqui et al22 and Bastide et al23 demonstrated that nADT before RP could improve long-term survival outcomes. However, both these studies included only high-risk patients with seminal vesicle invasion (pT3b); therefore, we cannot reach the same conclusion for localized PCa patients with clinical stage ≥ T2c, Gleason 8–10, or PSA>20 ng/ml.…”
Section: Discussionmentioning
confidence: 99%
“…SVI in PCa affects both patient prognosis and surgical strategy . In older series, SVI is reported to be as high as 26%; more recent series report SVI ranging from 5 to 9% …”
Section: Introductionmentioning
confidence: 99%